| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells
|
Qin, Baoli
|
|
2006
|
58 |
5 |
p. 577-584
|
artikel
|
| 2 |
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors
|
Felici, A.
|
|
2006
|
58 |
5 |
p. 673-680
|
artikel
|
| 3 |
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
|
Goss, G.
|
|
2006
|
58 |
5 |
p. 703-710
|
artikel
|
| 4 |
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer
|
Sato, Yasushi
|
|
2006
|
58 |
5 |
p. 570-576
|
artikel
|
| 5 |
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma
|
Ryan, Christopher W.
|
|
2006
|
58 |
5 |
p. 634-639
|
artikel
|
| 6 |
A phase I trial of carboplatin and etoposide for elderly (≥75 year-old) patients with small-cell lung cancer
|
Fukuda, Minoru
|
|
2006
|
58 |
5 |
p. 601-606
|
artikel
|
| 7 |
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer
|
Nagashima, Seiji
|
|
2006
|
58 |
5 |
p. 594-600
|
artikel
|
| 8 |
Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib
|
Perez-Ruixo, Juan Jose
|
|
2006
|
58 |
5 |
p. 681-691
|
artikel
|
| 9 |
Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells
|
Hurtubise, Annie
|
|
2006
|
58 |
5 |
p. 618-625
|
artikel
|
| 10 |
FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities
|
Konstantinopoulos, Panagiotis A.
|
|
2005
|
58 |
5 |
p. 711-715
|
artikel
|
| 11 |
High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2
|
Zhang, Yilong
|
|
2006
|
58 |
5 |
p. 561-569
|
artikel
|
| 12 |
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
|
Allegrini, Giacomo
|
|
2006
|
58 |
5 |
p. 585-593
|
artikel
|
| 13 |
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor
|
Froehner, Michael
|
|
2006
|
58 |
5 |
p. 716-718
|
artikel
|
| 14 |
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor
|
Al Safarjalani, Omar N.
|
|
2006
|
58 |
5 |
p. 692-698
|
artikel
|
| 15 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, Her-Shyong
|
|
2006
|
58 |
5 |
p. 654-664
|
artikel
|
| 16 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, Her-Shyong
|
|
|
58 |
5 |
p. 654-664
|
artikel
|
| 17 |
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy
|
Faltaos, Demiana William
|
|
2006
|
58 |
5 |
p. 626-633
|
artikel
|
| 18 |
Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro
|
Mori, Taisuke
|
|
2006
|
58 |
5 |
p. 665-672
|
artikel
|
| 19 |
Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel
|
Chang, Chih-Chuan
|
|
2006
|
58 |
5 |
p. 640-653
|
artikel
|
| 20 |
Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging
|
Port, Ruediger E.
|
|
2006
|
58 |
5 |
p. 607-617
|
artikel
|
| 21 |
The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice
|
Bruynzeel, Anna M. E.
|
|
2006
|
58 |
5 |
p. 699-702
|
artikel
|
Tijdschrift beschrijving